Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06521710

Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy

Phase I Clinical Trial: Pilot Study of Intraoperative Somatic-Autonomic Nerve Grafting Technique to Preserve Erectile Function in Patients With High Grade Prostate Cancer Undergoing Robotic Assisted Radical Prostatectomy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure

Detailed description

Patients will have baseline evaluation with International Index of Erectile Function-5 (IIEF-5) questionnaire and the Short Form McGill Pain Questionnaire (SF-MPQ)1, which will be re-evaluation at time of their standard of care post-operative visits at 4 weeks, 3-, 6-, 12- and 18-months. Post-operative safety will be assessed by recording any clinically detected complications during their peri- and post-operative care.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntraoperative Somatic-Autonomic Nerve GraftingA one-sided graft using a genitofemoral (GFN) nerve graft between one obturator nerve and the corpora cavernosa

Timeline

Start date
2024-09-01
Primary completion
2027-09-01
Completion
2027-12-01
First posted
2024-07-26
Last updated
2024-09-19

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06521710. Inclusion in this directory is not an endorsement.